Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Weili Jin
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Tianjin Medical University General Hospital,
Second Affiliated Hospital of Zhejiang University,
Tianjin Medical University,
Zhejiang University
ORCID:
0000-0002-1826-6312
Observed ORCID:
0000-0002-1826-6312
OpenAlex ID:
A5077243500
Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A
2022
·
Weili Jin
, Jixing Zhao
, et al.
·
Theranostics
·
112
PDF
A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep
2019
·
Yansheng Li
, Yu Ren
, et al.
·
Theranostics
·
105
Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells
2021
·
Jixing Zhao
, Weili Jin
, et al.
·
Pharmacological Research
·
68
HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas
2021
·
Yunfei Wang
, Kaikai Yi
, et al.
·
Frontiers in Immunology
·
60
PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma
2022
·
Eryan Yang
, Lin Wang
, et al.
·
Theranostics
·
55
PDF
Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke
2021
·
Weili Jin
, Ye Wu
, et al.
·
Theranostics
·
32
PDF
Tissue plasminogen activator disrupts the blood-brain barrier through increasing the inflammatory response mediated by pericytes after cerebral ischemia
2019
·
Eryan Yang
, Ying Cai
, et al.
·
Aging
·
31
PDF
Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas
2019
·
Qixue Wang
, Yanli Tan
, et al.
·
Aging
·
20
PDF
RETRACTED: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma
2021
·
Ye Wu
, Weili Jin
, et al.
·
Molecular Therapy
·
15
PDF
Universal theranostic CRISPR/Cas13a RNA-editing system for glioma
2023
·
Ye Wu
, Yunfei Wang
, et al.
·
Theranostics
·
8
PDF
Tumor Marker Test in Cerebrospinal Fluid for Leptomeningeal Metastasis Diagnosis and Response Assessment in Non‐Small‐Cell Lung Cancer
2025
·
Kaiyuan Huang
, Haifeng He
, et al.
·
European Journal of Neurology
·
7
PDF
Intrathecal pemetrexed efficacy and cerebrospinal fluid tumor marker response in refractory leptomeningeal metastasis of non-small-cell lung cancer: a single-arm phase II trial
2025
·
Qingsheng Xu
, Kaiyuan Huang
, et al.
·
BMC Medicine
·
7
PDF
Retraction Notice to: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma
2024
·
Ye Wu
, Weili Jin
, et al.
·
Molecular Therapy
Retraction of “Universal theranostic CRISPR/Cas13a RNA-editing system for glioma”
2024
·
Ye Wu
, Yunfei Wang
, et al.
·
Theranostics
PDF
Show more works
View as search
Works count:
14
Citation count:
520
H-index:
9
I10-index:
9
Year
Topic
Type